Sign In
Buy ATRA
$9.63
-0.270 (-2.73%)
At Close: Jun 03, 2026
Atara Biotherapeutics Inc (NASDAQ:ATRA) Stake Lessened by Bank of America Corp DE
09:08am, Wednesday, 22'nd Apr 2020
Bank of America Corp DE cut its stake in Atara Biotherapeutics Inc (NASDAQ:ATRA) by 28.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (
These are the best Chromebooks for students of any age!
09:00pm, Monday, 20'th Apr 2020
In the market for an education-focused Chromebook? These are our favorite ones!
Norges Bank Makes New $16.53 Million Investment in Atara Biotherapeutics Inc (NASDAQ:ATRA)
10:40am, Monday, 20'th Apr 2020
Norges Bank bought a new position in shares of Atara Biotherapeutics Inc (NASDAQ:ATRA) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC)
Geode Capital Management LLC Acquires 36,955 Shares of Atara Biotherapeutics Inc (NASDAQ:ATRA)
09:42am, Monday, 20'th Apr 2020
Geode Capital Management LLC lifted its holdings in shares of Atara Biotherapeutics Inc (NASDAQ:ATRA) by 5.3% during the 4th quarter, according to its most recent disclosure with the SEC. The fund own
Atara Biotherapeutics (NASDAQ:ATRA) Stock Price Down 2.5%
11:28am, Saturday, 18'th Apr 2020
Atara Biotherapeutics Inc (NASDAQ:ATRA)’s share price fell 2.5% during trading on Thursday . The company traded as low as $7.64 and last traded at $7.72, 29,474 shares changed hands during mid-day t
Zacks: Brokerages Anticipate Atara Biotherapeutics Inc (NASDAQ:ATRA) to Announce -$1.36 Earnings Per Share
10:44am, Saturday, 18'th Apr 2020
Wall Street analysts predict that Atara Biotherapeutics Inc (NASDAQ:ATRA) will announce earnings of ($1.36) per share for the current fiscal quarter, according to Zacks Investment Research. Zero analy
Analysts Offer Insights on Healthcare Companies: Pfenex (PFNX) and Autolus Therapeutics (AUTL)
02:26pm, Friday, 17'th Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Pfenex (PFNX) and Autolus Therapeutics (AUTL) with bullish
Analysts Offer Insights on Healthcare Companies: Pfenex (NYSE MKT: PFNX) and Autolus Therapeutics (NASDAQ: AUTL)
02:26pm, Friday, 17'th Apr 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Pfenex (PFNX
Mizuho Securities Remains a Buy on Gilead Sciences (GILD)
02:01pm, Friday, 17'th Apr 2020
Mizuho Securities analyst Salim Syed maintained a Buy rating on Gilead Sciences (GILD) today and set a price target of $81.00. The company's shares closed
Mizuho Securities Remains a Buy on Gilead Sciences (GILD)
02:00pm, Friday, 17'th Apr 2020
Mizuho Securities analyst Salim Syed maintained a Buy rating on Gilead Sciences (GILD – Research Report) today and set a
Canaccord Genuity Thinks Atara Biotherapeutics' Stock is Going to Recover
10:12am, Friday, 17'th Apr 2020
Canaccord Genuity analyst John Newman reiterated a Buy rating on Atara Biotherapeutics (ATRA) today and set a price target of $70.00. The company's shares
Canaccord Genuity Thinks Atara Biotherapeutics’ Stock is Going to Recover
10:12am, Friday, 17'th Apr 2020
Canaccord Genuity analyst John Newman reiterated a Buy rating on Atara Biotherapeutics (ATRA – Research Report) today and set a
Renewal date of health, motor insurance policies further extended to May 15
10:41am, Thursday, 16'th Apr 2020
If your current health, motor insurance policy is expiring between March 25, 2020 and May 3, 2020 and you are not able to renew your policy because of the country-wide lockdown, then you can renew suc
Seth Klarman Dials Down Akebia Therapeutics Stake
04:26pm, Tuesday, 14'th Apr 2020
Renowned guru slims position in biotech company that focuses on kidney disease Continue reading...
Seth Klarman Dials Down Akebia Therapeutics Stake
03:29pm, Tuesday, 14'th Apr 2020
Seth Klarman Dials Down Akebia Therapeutics Stake, Stocks: AKBA,TBPH,TBIO,ATRA,GOSS,PRTK, Seth Klarman, release date:Apr 14, 2020
